Cargando…

Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

OBJECTIVE: Glucagon-like peptide-1 (GLP-1) is released into the bloodstream after food intake. In addition to stimulating insulin release, it causes satiety and contributes to the termination of food intake. In this study, we investigated whether endogenous GLP-1 affects food-related brain activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heni, Martin, Kullmann, Stephanie, Gallwitz, Baptist, Häring, Hans-Ulrich, Preissl, Hubert, Fritsche, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731733/ https://www.ncbi.nlm.nih.gov/pubmed/26909313 http://dx.doi.org/10.1016/j.molmet.2015.09.007

Ejemplares similares

DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
por: Böhm, Anja, et al.
Publicado: (2017)

Sex differences in central insulin action: Effect of intranasal insulin on neural food cue reactivity in adults with normal weight and overweight
por: Wagner, Lore, et al.
Publicado: (2022)

Insulin Modulation of Magnetoencephalographic Resting State Dynamics in Lean and Obese Subjects
por: Stingl, Krunoslav T., et al.
Publicado: (2010)

Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
por: Gallwitz, Baptist
Publicado: (2022)

Brain insulin sensitivity is linked to adiposity and body fat distribution
por: Kullmann, Stephanie, et al.
Publicado: (2020)

Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger
por: Kullmann, Stephanie, et al.
Publicado: (2017)

GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond – New Insights 2015
por: Gallwitz, Baptist
Publicado: (2015)

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
por: Fritsche, Andreas, et al.
Publicado: (2020)

Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase
por: Hummel, Julia, et al.
Publicado: (2023)

Exercise restores brain insulin sensitivity in sedentary adults who are overweight and obese
por: Kullmann, Stephanie, et al.
Publicado: (2022)

GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans
por: Hanssen, Ruth, et al.
Publicado: (2021)

The Insulin-Mediated Modulation of Visually Evoked Magnetic Fields Is Reduced in Obese Subjects
por: Guthoff, Martina, et al.
Publicado: (2011)

Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
por: Kalra, Sanjay, et al.
Publicado: (2012)

Specific white matter tissue microstructure changes associated with obesity
por: Kullmann, Stephanie, et al.
Publicado: (2016)

Reduced cortical thickness associated with visceral fat and BMI
por: Veit, Ralf, et al.
Publicado: (2014)

Editorial: Reviews and Novel Clinical Perspectives on Semaglutide: A GLP-1 Receptor Agonist With Both Injectable and Oral Formulations
por: Meier, Juris J., et al.
Publicado: (2021)

Insulin sensitivity predicts cognitive decline in individuals with prediabetes
por: Willmann, Caroline, et al.
Publicado: (2020)

Basal Insulin Use With GLP-1 Receptor Agonists
por: Anderson, Sarah L., et al.
Publicado: (2016)

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021)

Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans
por: Wagner, Robert, et al.
Publicado: (2014)

Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
por: Ahlkvist, L, et al.
Publicado: (2013)

Insulin and GLP-1 infusions demonstrate the onset of adipose-specific insulin resistance in a large fasting mammal: potential glucogenic role for GLP-1
por: Viscarra, Jose A, et al.
Publicado: (2013)

Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10
por: Schwetz, Tara A., et al.
Publicado: (2014)

The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice
por: Montaner, Mireia, et al.
Publicado: (2023)

Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
por: Heni, Martin, et al.
Publicado: (2010)

GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production: Evidence for Predominance of GLP-2–Stimulated Postprandial Lipemia in Normal and Insulin-Resistant States
por: Hein, Gustavo J., et al.
Publicado: (2013)

Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion
por: Müssig, Karsten, et al.
Publicado: (2009)

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
por: Sathananthan, Airani, et al.
Publicado: (2010)

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
por: Salehi, Marzieh, et al.
Publicado: (2010)

Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
por: Raja, Umar Y, et al.
Publicado: (2015)

The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
por: Bae, Choon Sang, et al.
Publicado: (2017)

An Obesity Risk SNP (rs17782313) near the MC4R Gene Is Associated with Cerebrocortical Insulin Resistance in Humans
por: Tschritter, Otto, et al.
Publicado: (2011)

Integrative network analysis highlights biological processes underlying GLP-1 stimulated insulin secretion: A DIRECT study
por: Gudmundsdottir, Valborg, et al.
Publicado: (2018)

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
por: Matikainen, Niina, et al.
Publicado: (2016)

The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour
por: de Boer, Stefanie Amarens, et al.
Publicado: (2015)

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome
por: Bednarz, Krzysztof, et al.
Publicado: (2022)

Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer
por: Lutz, Stefan Zoltán, et al.
Publicado: (2022)

Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L
por: Blonde, Lawrence, et al.
Publicado: (2020)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

Pancreatic GLP-1r binding potential is reduced in insulin-resistant pigs
por: Malbert, Charles-Henri, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l69pq2flgv3nd5rd2g9etd14aj